Management of hepatocellular carcinoma
14 Nov 2012
Management of hepatocellular carcinoma
Nab-paclitaxel and gemcitabine combating pancreatic cancer
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)
Clinical trials and drug developments in pancreatic cancer
An improving outlook for liver cancer patients
Neuroendocrine tumours of the pancreas
Australia Pancreatic Cancer Genome Initiative
Addressing Asia’s high cancer incidence
Effects of metformin in pancreatic cancer with diabetes
Infectious diseases as a cause of cancer
Message from the President-Elect of ESTRO
Roundup of the EMCC 2011 conference